Genesco Statistics
Total Valuation
Genesco has a market cap or net worth of $231.03 million. The enterprise value is $682.11 million.
Important Dates
The last earnings date was Friday, March 7, 2025, before market open.
Earnings Date | Mar 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Genesco has 11.04 million shares outstanding. The number of shares has decreased by -3.62% in one year.
Current Share Class | 11.04M |
Shares Outstanding | 11.04M |
Shares Change (YoY) | -3.62% |
Shares Change (QoQ) | +2.27% |
Owned by Insiders (%) | 8.36% |
Owned by Institutions (%) | 95.24% |
Float | 10.12M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 13.72 |
PS Ratio | 0.10 |
Forward PS | 0.10 |
PB Ratio | 0.43 |
P/TBV Ratio | 0.45 |
P/FCF Ratio | 4.94 |
P/OCF Ratio | 2.63 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 9.85, with an EV/FCF ratio of 14.59.
EV / Earnings | n/a |
EV / Sales | 0.29 |
EV / EBITDA | 9.85 |
EV / EBIT | 40.70 |
EV / FCF | 14.59 |
Financial Position
The company has a current ratio of 1.60, with a Debt / Equity ratio of 0.89.
Current Ratio | 1.60 |
Quick Ratio | 0.22 |
Debt / Equity | 0.89 |
Debt / EBITDA | 1.32 |
Debt / FCF | 10.38 |
Interest Coverage | 3.39 |
Financial Efficiency
Return on equity (ROE) is -3.49% and return on invested capital (ROIC) is 0.99%.
Return on Equity (ROE) | -3.49% |
Return on Assets (ROA) | 0.79% |
Return on Invested Capital (ROIC) | 0.99% |
Return on Capital Employed (ROCE) | 1.75% |
Revenue Per Employee | $166,076 |
Profits Per Employee | -$1,349 |
Employee Count | 14,000 |
Asset Turnover | 1.74 |
Inventory Turnover | 3.05 |
Taxes
In the past 12 months, Genesco has paid $28.82 million in taxes.
Income Tax | 28.82M |
Effective Tax Rate | 309.63% |
Stock Price Statistics
The stock price has decreased by -22.85% in the last 52 weeks. The beta is 2.42, so Genesco's price volatility has been higher than the market average.
Beta (5Y) | 2.42 |
52-Week Price Change | -22.85% |
50-Day Moving Average | 33.79 |
200-Day Moving Average | 31.35 |
Relative Strength Index (RSI) | 25.93 |
Average Volume (20 Days) | 465,709 |
Short Selling Information
The latest short interest is 708,553, so 6.42% of the outstanding shares have been sold short.
Short Interest | 708,553 |
Short Previous Month | 553,972 |
Short % of Shares Out | 6.42% |
Short % of Float | 7.00% |
Short Ratio (days to cover) | 1.97 |
Income Statement
In the last 12 months, Genesco had revenue of $2.33 billion and -$18.89 million in losses. Loss per share was -$1.74.
Revenue | 2.33B |
Gross Profit | 1.10B |
Operating Income | 16.76M |
Pretax Income | -23.40M |
Net Income | -18.89M |
EBITDA | 69.22M |
EBIT | 16.76M |
Loss Per Share | -$1.74 |
Full Income Statement Balance Sheet
The company has $34.01 million in cash and $485.09 million in debt, giving a net cash position of -$451.08 million or -$40.87 per share.
Cash & Cash Equivalents | 34.01M |
Total Debt | 485.09M |
Net Cash | -451.08M |
Net Cash Per Share | -$40.87 |
Equity (Book Value) | 546.97M |
Book Value Per Share | 48.40 |
Working Capital | 228.97M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $87.89 million and capital expenditures -$41.13 million, giving a free cash flow of $46.75 million.
Operating Cash Flow | 87.89M |
Capital Expenditures | -41.13M |
Free Cash Flow | 46.75M |
FCF Per Share | $4.24 |
Full Cash Flow Statement Margins
Gross margin is 47.17%, with operating and profit margins of 0.72% and -0.81%.
Gross Margin | 47.17% |
Operating Margin | 0.72% |
Pretax Margin | 0.40% |
Profit Margin | -0.81% |
EBITDA Margin | 2.98% |
EBIT Margin | 0.72% |
FCF Margin | 2.01% |